Literature DB >> 29402788

Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Critical Accumulation of Rivaroxaban.

Andreas Koertge1, Reinhold Wasserkort1, Thomas Wild1, Steffen Mitzner1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29402788     DOI： 10.1159/000484923

Source DB:  PubMed          Journal:  Blood Purif        ISSN： 0253-5068            Impact factor:   2.614


× No keyword cloud information.
  9 in total

Review 1.  Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.

Authors:  L Christian Napp; Stephan Ziegeler; Detlef Kindgen-Milles
Journal:  Blood Purif       Date:  2019-05-16       Impact factor: 2.614

Review 2.  Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy.

Authors:  Joerg Scheier; Peter J Nelson; Antoine Schneider; Sébastien Colombier; Detlef Kindgen-Milles; Efthymios N Deliargyris; Thomas D Nolin
Journal:  Crit Care Explor       Date:  2022-05-09

3.  Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.

Authors:  Elvira Grandone; Filippo Aucella; Doris Barcellona; Giuliano Brunori; Giacomo Forneris; Paolo Gresele; Marco Marietta; Daniela Poli; Sophie Testa; Armando Tripodi; Simonetta C Genovesi
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

4.  Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider.

Authors:  Patrick M Honore; Aude Mugisha; Luc Kugener; Sebastien Redant; Rachid Attou; Andrea Gallerani; David De Bels
Journal:  Crit Care       Date:  2020-05-08       Impact factor: 9.097

5.  Hemoadsorption to treat severe iatrogenic intoxication with Patent Blue: a case report.

Authors:  Fabio Silvio Taccone; Mickael Gardette; Jacques Creteur; Alexandre Brasseur; Sophie Lorent; David Grimaldi
Journal:  J Med Case Rep       Date:  2021-02-09

Review 6.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

7.  Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.

Authors:  Ilad Alavi Darazam; Muhanna Kazempour; Mohamad Amin Pourhoseingholi; Firouze Hatami; Mohammad Mahdi Rabiei; Farid Javandoust Gharehbagh; Mahdi Amirdosara; Mohammadreza Hajiesmaeili; Minoosh Shabani; Shervin Shokouhi; Legha Lotfollahi; Masoud Mardani; Maryam Haghighi-Morad; Amir Ahmad Nassiri; Davoud Rangraz; Hassan Falahaty; Hosein Syami; Yaghoob Irannejad; Maryam Fallah; Masoud Zangi; Navid Shafigh
Journal:  Blood Purif       Date:  2022-05-17       Impact factor: 3.348

Review 8.  Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery-a systematic review.

Authors:  Marijana Matejic-Spasic; Kambiz Hassan; Matthias Thielmann; Stephan Geidel; Robert F Storey; Michael Schmoeckel; Harriet Adamson; Efthymios N Deliargyris; Daniel Wendt
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

9.  Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).

Authors:  Elvira Grandone; Filippo Aucella; Doris Barcellona; Giuliano Brunori; Giacomo Forneris; Paolo Gresele; Marco Marietta; Daniela Poli; Sophie Testa; Armando Tripodi; Simonetta Genovesi
Journal:  J Nephrol       Date:  2020-07-31       Impact factor: 3.902
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.